{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:56:53Z","timestamp":1787237813455,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008307","name":"Promedica Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008307","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["PZ00P3_216616"],"award-info":[{"award-number":["PZ00P3_216616"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jns.2026.125796","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:26:59Z","timestamp":1770424019000},"page":"125796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Persistent parvovirus B19 DNAemia in B-cell depletion: Implications for family planning in multiple sclerosis and related disorders"],"prefix":"10.1016","volume":"482","author":[{"given":"Lorenz","family":"Karnbrock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Herwerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido Vincent","family":"Bloemberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Alma","family":"Abela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Kana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2026.125796_bb0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jns.2026.125796_bb0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jns.2026.125796_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.125796_bb0020","series-title":"Diagnose Und Therapie der Multiplen Sklerose, Neuromyelitis-Optica- Spektrum-Erkrankungen und MOG-IgG-assoziierten Erkrankungen","author":"Hemmer","year":"2024"},{"issue":"4","key":"10.1016\/j.jns.2026.125796_bb0025","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1474-4422(22)00426-4","article-title":"Family planning considerations in people with multiple sclerosis","volume":"22","author":"Krysko","year":"2023","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jns.2026.125796_bb0030","first-page":"26","article-title":"Recommendations for the treatment of multiple sclerosis in family planning, pregnancy and lactation in Switzerland: immunotherapy, clinical and translational","volume":"8","author":"Graber","year":"2024","journal-title":"Neuroscience"},{"issue":"22","key":"10.1016\/j.jns.2026.125796_bb0035","doi-asserted-by":"crossref","first-page":"e2504","DOI":"10.1212\/WNL.0000000000201260","article-title":"Long-term effectiveness and safety of rituximab in neuromyelitis Optica Spectrum disorder and MOG antibody disease","volume":"99","author":"Barreras","year":"2022","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.jns.2026.125796_bb0040","doi-asserted-by":"crossref","first-page":"e1854","DOI":"10.1212\/WNL.0000000000010376","article-title":"Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension","volume":"95","author":"Hauser","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2026.125796_bb0045","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa1917246","article-title":"Ofatumumab versus Teriflunomide in Multiple Sclerosis","volume":"383","author":"Hauser","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jns.2026.125796_bb0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/jamaneurol.2019.3365","article-title":"Infection risks among patients with multiple sclerosis treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies","volume":"77","author":"Luna","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2026.125796_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104400","article-title":"Infection risk in a real-world cohort of patients treated with long-term B-cell depletion for autoimmune neurologic disease","volume":"68","author":"Peters","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jns.2026.125796_bb0060","unstructured":"Annual Epidemiological Reports (AERs), 2024."},{"key":"10.1016\/j.jns.2026.125796_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.annepidem.2025.06.007","article-title":"Outpatient insurance data indicate increased numbers of Parvovirus B19 infections and -associated miscarriages during the 2024 epidemic in the German federal state Saarland","volume":"108","author":"Sternjakob","year":"2025","journal-title":"Ann. Epidemiol."},{"issue":"1","key":"10.1016\/j.jns.2026.125796_bb0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13760-019-01227-y","article-title":"Parvovirus B19 infection in a patient with multiple sclerosis treated with ocrelizumab","volume":"120","author":"Lattanzi","year":"2020","journal-title":"Acta Neurol. Belg."},{"issue":"9","key":"10.1016\/j.jns.2026.125796_bb0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.medcli.2020.01.016","article-title":"Parvovirus B19 infection in a patient with multiple sclerosis treated with rituximab","volume":"156","author":"Ruiz Molina","year":"2021","journal-title":"Med. Clin. (Barc.)"},{"issue":"3","key":"10.1016\/j.jns.2026.125796_bb0080","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood.V96.3.1184.015k54_1184_1186","article-title":"Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab","volume":"96","author":"Sharma","year":"2000","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.jns.2026.125796_bb0085","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.25.2400339","article-title":"An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024","volume":"29","author":"d\u2019Humieres","year":"2024","journal-title":"Euro Surveill."},{"issue":"9","key":"10.1016\/j.jns.2026.125796_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29892","article-title":"Differential diagnosis on measles and rubella discarded cases highlights a sharp increase in parvovirus B19 infections in Milan, northern Italy, in the first months of 2024","volume":"96","author":"Fappani","year":"2024","journal-title":"J. Med. Virol."},{"issue":"24","key":"10.1016\/j.jns.2026.125796_bb0095","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.24.2400299","article-title":"Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, January to March 2024","volume":"29","author":"Nordholm","year":"2024","journal-title":"Euro Surveill."},{"issue":"9","key":"10.1016\/j.jns.2026.125796_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29878","article-title":"Unexpected high incidence of parvovirus B19 nucleic acid detection in German blood donors in the winter\/spring season 2023\/2024","volume":"96","author":"Plumers","year":"2024","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.jns.2026.125796_bb0105","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S1473-3099(24)00560-7","article-title":"Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature","volume":"25","author":"Berti","year":"2025","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.jns.2026.125796_bb0110","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s10067-016-3379-6","article-title":"Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis","volume":"35","author":"Giraud","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.jns.2026.125796_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/v15051124","article-title":"Clinical presentation of parvovirus B19 infection in adults living with HIV\/AIDS: a case series","volume":"15","author":"Mendes-de-Almeida","year":"2023","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.jns.2026.125796_bb0120","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ajh.20200","article-title":"Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy","volume":"77","author":"Isobe","year":"2004","journal-title":"Am. J. Hematol."},{"issue":"10","key":"10.1016\/j.jns.2026.125796_bb0125","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/brain\/awy239","article-title":"Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis","volume":"141","author":"Baker","year":"2018","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2026.125796_bb0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","article-title":"Memory B cells activate brain-homing, autoreactive CD4(+) T cells in multiple sclerosis","volume":"175","author":"Jelcic","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jns.2026.125796_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jmv.20513","article-title":"Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection","volume":"78","author":"Corcoran","year":"2006","journal-title":"J. Med. Virol."},{"issue":"9","key":"10.1016\/j.jns.2026.125796_bb0140","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1007\/s10072-022-06197-3","article-title":"Comparative safety of high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis","volume":"43","author":"Sladowska","year":"2022","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2026.125796_bb0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jcv.2013.07.007","article-title":"Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with Anaemia","volume":"58","author":"Plentz","year":"2013","journal-title":"J. Clin. Virol."},{"issue":"6","key":"10.1016\/j.jns.2026.125796_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/v9060149","article-title":"Impact of parvovirus B19 viremia in liver transplanted children on anemia: a retrospective study","volume":"9","author":"Wurdinger","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.jns.2026.125796_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fmed.2018.00004","article-title":"Parvovirus B19: what is the relevance in transfusion medicine?","volume":"5","author":"Juhl","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"issue":"5","key":"10.1016\/j.jns.2026.125796_bb0160","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1537-2995.2008.01704.x","article-title":"Persistent infection by human parvovirus B19 in qualified blood donors","volume":"48","author":"Matsukura","year":"2008","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.jns.2026.125796_bb0165","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s00404-024-07644-6","article-title":"Prenatal parvovirus B19 infection","volume":"310","author":"Kagan","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"issue":"8","key":"10.1016\/j.jns.2026.125796_bb0170","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1016\/S1473-3099(24)00373-6","article-title":"Extreme upsurge of parvovirus B19 resulting in severe fetal morbidity and mortality","volume":"24","author":"Russcher","year":"2024","journal-title":"Lancet Infect. Dis."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2600078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2600078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:31:08Z","timestamp":1771680668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X2600078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"alternative-id":["S0022510X2600078X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.125796","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent parvovirus B19 DNAemia in B-cell depletion: Implications for family planning in multiple sclerosis and related disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"125796"}}